AAIC 2022

Mayo Clinic Laboratories offers innovative testing solutions for the early detection of Alzheimer's disease. Our evaluations, which use CSF biomarkers to achieve a high concordance with an amyloid positron emission tomography (PET) scan, deliver faster results and provide new hope for correctly diagnosing and managing Alzheimer's disease along with other dementias. Learn more about our Alzheimer’s disease testing through the resources below.

Resources

Digital Resources

ADEVL Test in Focus Podcast

Alzheimer’s Disease Overview

FDA-approved test expands options for Alzheimer's disease [Test in Focus]

Specialty Webinar: Role of CSF in Alzheimer’s Disease

Printable Documents

Neurology Test Requisition Form

Alzheimer’s Disease Flyer

Neurodegenerative Disease Flyer

Contact us